Parliament Website

Post-Marketing Drugs Studies Regulation

EDM number 239 in 2012-13, proposed by Keith Vaz on 20/06/2012.
Categorised under the topics of Medicine and Research and innovation.

That this House is deeply concerned that post-marketing drugs studies are being used for commercial and not scientific reasons by some drugs companies; notes that recent research has shown that tens of thousands of diabetics in less developed countries have been put on expensive new medication which does not have additional clinical benefits due to lax international regulations; further notes that some patients are spending a third of their household incomes on the new medication; and calls for the Government to hold discussions on tightening international regulations on post-marketing studies by drugs companies.

This motion has been signed by a total of 17 MPs.

Keith Vaz20/06/2012Leicester EastLabourProposed
Alan Meale21/06/2012MansfieldLabourSeconded
Sandra Osborne21/06/2012Ayr, Carrick and CumnockLabourSeconded
Jeremy Corbyn21/06/2012Islington NorthLabourSeconded
Mark Durkan21/06/2012FoyleSocial Democratic and Labour PartySeconded
Kelvin Hopkins25/06/2012Luton NorthLabourSeconded
Peter Bottomley25/06/2012Worthing WestConservativeSigned
Lindsay Roy25/06/2012GlenrothesLabourSigned
John McDonnell25/06/2012Hayes and HarlingtonLabourSigned
Margaret Ritchie25/06/2012South DownSocial Democratic and Labour PartySigned
Martin Caton26/06/2012GowerLabourSigned
John Leech26/06/2012Manchester, WithingtonLiberal DemocratSigned
Virendra Sharma26/06/2012Ealing, SouthallLabourSigned
Michael Crockart26/06/2012Edinburgh WestLiberal DemocratSigned
David Anderson27/06/2012BlaydonLabourSigned
Yasmin Qureshi27/06/2012Bolton South EastLabourSigned
David Crausby11/07/2012Bolton North EastLabourSigned

Download raw data as csv or xml.